INTRODUCTION
Although the antidiuretic effect of vasopressin is well known, attention has been centered recently on its natriuretic and phosphaturic effects when it is given in pharmacologic doses (1) (2) (3) natriuresis, and phosphaturia analogous to the effect of potent diuretics. Martinez-Maldonado, Eknoyan, and Suki (3) also showed unilateral natriuresis in the dog by direct intrarenal-artery injection of small doses of vasopressin as well as dibutyryl cyclic adenosine 3',5'-monophosphate (cyclic AMP).' Because of the concomitant phosphaturia, they concluded that vasopressin exerts natriuresis by stimulating the production of cyclic AMP in the proximal tubule of the kidney, thereby reducing its sodium and phosphate reabsorption. On the other hand, the available micropuncture studies in the literature (4) (5) (6) failed to demonstrate any effect of vasopressin on proximal tubule sodium transport in the animals undergoing water diuresis. Our present micropuncture study was undertaken to reexamine whether proximal tubule transport of sodium and phosphate could be altered in thyroparathyroidectomized (TPTX) dogs by administration of vasopressin in the doses frequently employed in experimental conditions. Our results indicate that the pharmacologic doses of vasopressin inhibit phosphate transport in the proximal tubule but that its effect on sodium transport appears to be related to changes in arterial blood pressure and glomerular filtration rate (GFR) associated with vasopressin administration.
METHODS
Recollection micropuncture study was performed in 11 mongrel dogs of either sex, weighing 12-20 kg. All animals were maintained on Fromm Dog Meal (Federal Food, Inc., Thiensville, Wis.) containing 34 mmol phosphate/100 g, and the average daily phosphate intake by these animals was appoximately 100 mmol/day. The animals were thyroparathyroidectomized 3 days before the micropuncture experiments and calcium carbonate was added to the diet to 'Abbreviations used in this paper: GFR, glomerular filtration rate; PAH, para-aminohippurate; TF/P1., tubule fluid-to-plasma inulin ratio; TF/UFpo4, tubule fluid-toplasma ultrafilterable phosphate ratio; TPTX, thyroparathyroidectomized; TCH2o, free water reabsorption. prevent the development of tetany. Water was allowed ad lib until the morning of micropuncture experiment. Animals were prepared for micropuncture in a manner previously described (7) . A femoral artery was cannulated for measurement of blood pressure and both ureters were catheterized for collection of urine. Recollection micropuncture study was carried out during the control phase of antidiuresis, which was followed by a second phase with continuous infusion of vasopressin (Pitressin, Parke, Davis & Co., Detroit, Mich.) at 50 mU/kg/h. 45 min1 h was allowed before the micropuncture was resumed in the second phase and fluid infusions were given at rates that would replace the urinary loss and avoid any volume expansion throughout the experiment. The micropuncture experiments were divided into two groups according to blood pressure responses after vasopressin administration. Group I consisted of five experiments in which mean arterial blood pressure increased by 14 mm Hg or more, whereas in the remaining six experiments, group II, mean blood pressure either remained relatively unchanged or decreased slightly.
Standard clearance techniques were employed for 15-min collection periods. The plasma ultrafiltrate was obtained by centrifugation in a collodion bag (8) under optimal pH control. Tubule fluid was analyzed for inulin by the ultramicrofluorometric method (9) , and for phosphate by a modification of the microcolorimetric method, with ascorbic acid as the reducing agent (10) . Phosphate in the plasma, ultrafiltrate, and urine was determined by AutoAnalyzer method with stannous chloride-hydrazine (11) , inulin and para-aminohippurate (PAH) by AutoAnalyzer methods (12) and sodium by flame photometry (Instrumentation Laboratory, Inc., Lexington, Mass.). The validity of control recollection for inulin and phosphate in TPTX dogs in our laboratory has previously been documented (7) . Micropuncture and clearance data were analyzed statistically, with Student's t test for paired comparison (13) of the mean values per animal between the two experimental phases.
RESULTS
After infusion of vasopressin at 50 mU/kg/h in 11 TPTX dogs, mean arterial blood pressure increased in 5 dogs by 20±3 mm Hg, whereas the pressure remained unchanged in 6 before and after vasopressin. Mean GFR of the micropunctured kidney increased significantly in the first group by 10.3+2.6 ml/min. In the second group, GFR increased in four and decreased in two dogs with the mean remaining unchanged (P> 0.7). Since the animals with increased mean blood pressure showed a response in proximal tubule sodium reabsorption different from those without increased blood pressure, micropuncture data for the two groups were considered separately. However, clearance data for all 11 experiments were pooled together, as no significant difference in the pattern of urinary electrolyte excretion between the two groups was observed.
Micropuncture data in the two groups of animals are summarized in Table I . In the first group with increased blood pressure, mean proximal tubule fluid-to- Vasopressin Effect on Phosphate Transport Abbreviations: C, control phase; E, experimei as in Table I .
plasma (TF/P) inulin ratio fell significantly by 0.16± 0.03, while this value remained unchanged at 1.60 in the second group without blood pressure change. In contrast, mean proximal tubule fluid-to-plasma ultrafilterable (TF/UF) phosphate ratio increased significantly in both groups by 0.19±0.07 and 0.19±0.04, respectively. These changes are depicted in Fig. 1 Clearance data of all 11 dogs before and after vasopressin administration are summarized in Table III . Mean urine flow increased slightly (P < 0.05), suggesting a small diuretic effect of vasopressin when given in pharmacologic doses during antidiuresis. Mean urine osmolality did not change significantly but mean free water reabsorption (TCHi20) increased slightly after vasopressin. Mean fractional excretion of sodium increased DISCUSSION Our present micropuncture study showed that vasopressin, when given in the doses employed, effects phosphaturia by inhibition of fractional proximal tubule phosphate reabsorption. This effect was independent of changes in circulating parathyroid hormone level, systemic arterial blood pressure, or GFR, since these parameters were all relatively unchanged in the second group of animals studied. In contrast, reduction in fractional proximal tubule sodium reabsorption was observed only in the first group with increased arterial blood pressure and GFR. The reasons for the variable blood pressure changes after vasopressin are unknown, but they may represent differences' in individual responsiveness to the given dose of vasopressin. An inhibitory effect of vasopressin on proximal tubule sodium reabsorption has not been demonstrated previously (4) (5) (6) . The earlier micropuncture studies were carried out because there may be stimulation of sodium transport by vasopressin as suggested by toad bladder studies (14) , but such a stimulatory effect could not be shown except in the isolated collecting tubules (15) . It is not clear
whether the failure to demonstrate proximal tubule effects of vasopressin by others was due to the use of hydrated animals undergoing water diuresis in their studies, as compared to antidiuretic animals used in ours. Also, their animals were not divided according to blood pressure changes, which were apparently responsible for our data. It has been demonstrated that acute increase in arterial blood pressure may reduce proximal tubule sodium reabsorption, presumably by increasing hydrostatic pressure in the peritubular capillaries (16) . In addition, increased GFR in the first group of our study may also have contributed to the observed reduction in fractional sodium reabsorption in the proximal tubule. In contrast to the dependence of changes in proximal tubule sodium transport on elevated blood pressure, natriuresis occurred in all animals, regardless of blood pressure changes. This strongly suggests that a distal effect of vasopressin on sodium transport was mainly responsible for the observed natriuresis. Indeed, such an inhibitory effect of vasopressin on distal nephron has been demonstrated by Antoniou, Burke, Robinson, and Clapp (6) .
In our study, mean proximal TF/UF phosphate during antidiuresis in TPTX dogs was relatively high at 0.6-0.7, which was probably related to high phosphate intake (7), since administration of aluminum hydroxide to reduce intestinal phosphate absorption resulted in a lower mean proximal TF/UF phosphate of 0.45.' After administration of vasopressin, the magnitude of changes in fractional phosphate reabsorption in the proximal tubule was similar to or greater than that at the final urine level, suggesting that the phosphaturic effect of vasopressin could be accounted for mainly by its action in the proximal tubule.
The mechanism by which vasopressin exerts its effect on proximal tubule phosphate transport is unknown. Martinez-Maldonado et al. (3) injected dibutyryl cyclic AMP to the renal artery and demonstrated phosphaturia similar to that caused by vasopressin. Since vasopressin is known to stimulate adenyl cyclase to increase the production of cyclic AMP, they postulated that natriuretic and phosphaturic effects of vasopressin may be mediated through the cyclic AMP system in the proximal tubule cells. Our finding of reduced phosphate transport in the proximal tubule with vasopressin as well as the findings of others with dibutyryl cyclic AMP (17) are consistent with this concept. However, absence of changes in proximal tubule sodium transport after vasopressin when systemic blood pressure was unchanged suggests a slightly different response of the proximal tubule transport to vasopressin, as compared with that of cyclic AMP or parathyroid hormone (7, 17) . This dissociation of sodium and phosphate transport in the proximal tubule has also been demonstrated in saline-loaded dogs after alterations of parathyroid hormone levels (7) . The possibility of a release by vasopressin of extrarenal phosphaturic factors other than parathyroid hormone also cannot be excluded, as Dimond and Buckalew (18) showed suggestive evidence of an extrarenal natriuretic factor after vasopressin administration. Whatever the mechanism may be, the fact that significant phosphaturia and natriuresis can be induced by administration of vasopressin in the doses frequently employed in experimental conditions indicates that such pharmacologic effects of vasopressin should be taken into consideration when phosphate and sodium transport is studied under such conditions.
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